Allen Lichter, MD - Chair
Allen S. Lichter, MD, earned his bachelor’s and medical degrees from the University of Michigan. He trained in radiation oncology at University of California, San Francisco, before joining the faculty at Johns Hopkins University, and later the National Cancer Institute. He has served as Chair of the Department of Radiation Oncology and later as Dean of the Medical School at Michigan. His most recent position was CEO of the American Society of Clinical Oncology (ASCO) from 2006-2016.
Mark J. Ratain, MD - Treasurer
Dr. Ratain has been a faculty member in the Department of Medicine at The University of Chicago since 1986, and is currently the Leon O. Jacobson Professor of Medicine, the Director of the Center for Personalized Therapeutics and Chief Hospital Pharmacologist. In addition, he serves as the Associate Director for Clinical Sciences in the University’s Comprehensive Cancer Center, and leads the University of Chicago’s phase I oncology trials program. Dr. Ratain’s research has historically focused on the development of new oncology drugs and diagnostics, but is increasingly focused on the new discipline of interventional pharmacoeconomics. He is the recipient of awards from multiple organizations, including the American Association of Pharmaceutical Scientists, the American Society for Clinical Pharmacology and Therapeutics, the American Society of Clinical Oncology, the American College of Clinical Pharmacology, and the Pharmaceutical Research and Manufacturers Association Foundation.
Michael Stebbins, PhD - Member-at Large
Michael Stebbins is the President of Science Advisors, a science and health consulting firm he founded in 2018 to provide science, technology, and public policy guidance to private companies, philanthropies, and non-profit organizations. He previously served as the Vice President of Science and Technology for the Laura and John Arnold Foundation and as the Assistant Director for Biotechnology in the Obama White House Office of Science and Technology Policy. He received his B.S. in biology at SUNY Stony Brook and his Ph.D. in genetics while working at Cold Spring Harbor Laboratory.
David A. Hyman, MD, JD - Member-at Large
David A. Hyman is a Professor of Law at Georgetown University. Hyman served as special counsel on the Federal Trade Commission, where he organized and led hearings on health care and competition - leading to the first joint report issued by the Federal Trade Commission and Department of Justice, “Improving Health Care: A Dose of Competition.” He is the co-author of Overcharged: Why Americans Pay Too Much For Health Care (2018).
Dr. Ian F. Tannock - Co-Chair
Dr. Ian F. Tannock is Professor Emeritus of Medical Oncology at the Princess Margaret Cancer Centre and the University of Toronto, Toronto, Ontario. His clinical research has focused on methodology for clinical trials, and he has led practice-changing trials for prostate cancer. Dr. Tannock was a member of the Board of Directors of ASCO (2001-2004). He received an honorary degree (DSc) from London University, UK (2009), was the first non-European to receive the ESMO award (2012), and received the Allen Lichter award for leadership and innovation from ASCO (2019). Dr. Tannock is a Member of the Order of Canada.